Literature DB >> 17367356

Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients.

Carol Chen-Scarabelli1, Tiziano M Scarabelli.   

Abstract

BACKGROUND: Chronic renal insufficiency (CRI) has been associated with increased risk of cardiovascular morbidity and mortality. However, there is limited knowledge regarding this association and the effect of renal dysfunction on survival benefit in patients with implantable cardioverter-defibrillators (ICDs).
METHODS: We investigated whether there was an association between CRI (defined as serum creatinine levels >or=1.5 mg/dL) and increased risk of mortality in ICD recipients. We retrospectively studied all patients (n = 336) followed within our ICD clinic in a 2.5-year period. CRI, ventricular tachycardia (VT), cardiomyopathy (CM), and mortality were recorded. Ischemic CM was defined as the presence of coronary artery disease (CAD) and left ventricular ejection fraction <or= 30%.
RESULTS: Despite no significant difference in CAD and VT occurrence between CRI and non-CRI groups in the overall population, there was a significantly higher mortality rate in the CRI group (P < 0.0001).
CONCLUSION: CRI is a significant independent predictor of mortality in ICD recipients. Further investigation is needed to determine whether prevention, early detection, and more aggressive intervention in the treatment of CRI will reduce the incidence of mortality in this population.

Entities:  

Mesh:

Year:  2007        PMID: 17367356     DOI: 10.1111/j.1540-8159.2007.00677.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

Review 1.  Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients.

Authors:  Mohammed Shurrab; Dennis T Ko; Yazan Zayed; Sankar D Navaneethan; Nour Yadak; Abeer Yaseen; Anna Kaoutskaia; Waad Qamhia; Zakaria Hamdan; Saleem Haj-Yahia; Douglas S Lee; David Newman; Jeff S Healey; Paula Harvey; Eugene Crystal
Journal:  J Interv Card Electrophysiol       Date:  2018-07-30       Impact factor: 1.900

2.  Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients.

Authors:  Faris Khan; Evan Adelstein; Samir Saba
Journal:  J Interv Card Electrophysiol       Date:  2010-08       Impact factor: 1.900

3.  Predictors of mortality amongst recipients of implantable cardioverter defibrillators for secondary prevention of cardiac arrest.

Authors:  Sunil K Agarwal; Ish Singla; Haitham Hreybe; Samir Saba
Journal:  Indian Pacing Electrophysiol J       Date:  2007-10-22

4.  A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs).

Authors:  Tien-Hsing Chen; Hung-Ta Wo; Po-Cheng Chang; Chun-Chieh Wang; Ming-Shien Wen; Chung-Chuan Chou
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.